abrdn Healthcare Investors (HQH) To Go Ex-Dividend on August 24th

abrdn Healthcare Investors (NYSE:HQH) declared a quarterly dividend on Tuesday, August 11th. Shareholders of record on Monday, August 24th will be given a dividend of 0.66 per share by the financial services provider on Wednesday, September 30th. This represents a c) annualized dividend and a yield of 10.8%. The ex-dividend date of this dividend is Monday, August 24th.

abrdn Healthcare Investors Trading Up 2.1%

Shares of NYSE:HQH opened at $24.35 on Friday. The business has a fifty day simple moving average of $21.88 and a 200 day simple moving average of $20.10. abrdn Healthcare Investors has a 1 year low of $16.10 and a 1 year high of $24.85.

Hedge Funds Weigh In On abrdn Healthcare Investors

Several hedge funds have recently bought and sold shares of the business. Bollard Group LLC acquired a new stake in shares of abrdn Healthcare Investors in the first quarter worth about $25,000. Geneos Wealth Management Inc. raised its position in shares of abrdn Healthcare Investors by 9,232.3% in the second quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 2,862 shares during the period. Advisory Services Network LLC bought a new position in shares of abrdn Healthcare Investors in the third quarter valued at approximately $97,000. Global Retirement Partners LLC acquired a new stake in shares of abrdn Healthcare Investors in the fourth quarter worth $106,000. Finally, PNC Financial Services Group Inc. acquired a new stake in shares of abrdn Healthcare Investors in the fourth quarter worth $107,000. 32.60% of the stock is owned by institutional investors and hedge funds.

About abrdn Healthcare Investors

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.